Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

DIAGNOSTIC LABORATORY SCIENCE, INC

NPI: 1861413023 · GARDEN GROVE, CA 92841 · Clinical Medical Laboratory · NPI assigned 07/22/2006

$7.69M
Total Medicaid Paid
400,097
Total Claims
349,978
Beneficiaries
197
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialHISERODT, JOHN (PRESIDENT/MEDICAL DIRECTOR)
NPI Enumeration Date07/22/2006

Related Entities

Other providers sharing the same authorized official: HISERODT, JOHN

ProviderCityStateTotal Paid
PATHLAB SERVICES INC GARDEN GROVE CA $6.97M
CENTRAL MEDICAL DIAGNOSTIC LABORATORY,INC. CYPRESS CA $3K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 79,407 $25K
2019 345 $1K
2020 15,314 $817K
2021 77,527 $2.57M
2022 97,897 $2.71M
2023 19,876 $281K
2024 109,731 $1.29M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 57,336 35,742 $3.45M
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 3,935 3,759 $824K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 29,794 17,228 $558K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 5,444 3,074 $463K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 1,450 784 $127K
87631 2,926 2,774 $123K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 4,643 1,984 $121K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 2,439 2,326 $109K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 9,973 9,725 $92K
87634 2,093 1,949 $79K
87486 3,241 3,037 $75K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 4,128 4,069 $74K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 4,163 4,105 $73K
87581 3,111 2,911 $65K
84443 Thyroid stimulating hormone (TSH) 10,833 10,578 $59K
80061 Lipid panel 9,271 9,202 $57K
87541 2,731 2,574 $57K
86235 1,302 1,283 $53K
80053 Comprehensive metabolic panel 12,777 12,518 $50K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 3,887 2,644 $47K
87505 716 703 $45K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 14,349 13,928 $42K
83036 Hemoglobin; glycosylated (A1C) 11,139 10,944 $41K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 169 158 $40K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2,864 2,834 $36K
88305 Level IV - Surgical pathology, gross and microscopic examination 1,155 1,138 $33K
86003 274 273 $32K
80074 1,315 1,305 $26K
84481 4,401 4,295 $26K
82172 1,014 1,006 $23K
86780 2,862 2,830 $22K
82607 5,694 5,528 $22K
87077 6,439 6,207 $21K
87481 1,169 1,102 $20K
86696 1,738 1,723 $20K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 516 290 $19K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 459 274 $19K
84403 2,092 2,048 $19K
87500 721 707 $17K
82746 4,523 4,405 $17K
87086 Culture, bacterial; quantitative colony count, urine 7,454 7,131 $16K
82670 909 902 $16K
84153 2,609 2,575 $15K
82728 3,671 3,590 $15K
82627 872 867 $14K
86695 1,721 1,706 $14K
88142 1,146 1,144 $14K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 683 682 $14K
87640 818 802 $13K
88112 968 960 $13K
87653 831 816 $13K
84305 747 742 $12K
84439 4,574 4,443 $12K
83090 2,444 2,369 $11K
86803 1,528 1,512 $11K
87506 74 71 $11K
84402 954 952 $11K
86481 391 389 $11K
88312 982 963 $10K
87088 4,533 4,389 $10K
81001 6,684 6,521 $10K
84144 695 689 $10K
82533 797 790 $10K
83001 869 863 $10K
87340 1,761 1,746 $10K
83002 812 807 $9K
83003 718 713 $9K
84270 1,387 1,361 $9K
86038 2,572 2,371 $9K
84146 689 684 $8K
83540 4,447 4,292 $8K
86147 178 178 $8K
86146 165 165 $8K
83550 3,630 3,549 $8K
84154 1,953 1,896 $8K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 157 157 $7K
87480 229 225 $7K
86140 3,329 3,303 $7K
83525 811 804 $6K
83735 4,587 4,408 $6K
83010 1,143 1,130 $6K
0099U 12 12 $6K
84466 960 928 $6K
84550 5,653 5,442 $6K
87186 1,475 1,452 $5K
87070 1,099 1,067 $5K
82550 3,279 3,207 $5K
86769 182 159 $5K
86225 1,066 1,049 $5K
83690 1,075 1,072 $5K
82523 369 356 $5K
82150 1,018 1,014 $5K
83516 201 201 $5K
84480 655 645 $4K
87081 728 696 $4K
84100 4,061 3,950 $4K
83013 143 141 $4K
86403 1,059 1,014 $3K
86762 405 403 $3K
87511 198 195 $3K
84702 379 356 $3K
87184 2,363 2,273 $3K
82785 404 389 $3K
80076 1,692 1,610 $3K
88304 96 92 $3K
86430 1,158 1,152 $3K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 155 153 $3K
87563 231 226 $3K
83695 297 297 $2K
84436 678 660 $2K
85651 4,577 4,473 $2K
87071 420 407 $2K
82043 1,913 1,881 $2K
87076 410 408 $2K
87660 215 211 $2K
86200 1,182 1,140 $2K
82248 816 809 $2K
88311 958 939 $2K
83970 2,036 1,992 $2K
82951 251 240 $2K
86706 467 462 $2K
85044 764 760 $2K
83655 194 194 $1K
84479 454 447 $1K
82040 886 823 $1K
83880 1,944 1,851 $1K
82950 386 383 $1K
86376 178 177 $1K
82672 140 139 $1K
80050 General health panel 509 506 $975.95
82570 1,644 1,606 $957.96
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 32 32 $936.25
86160 268 267 $915.64
85027 281 281 $839.49
86704 295 293 $808.29
82610 1,175 1,108 $755.79
82565 1,174 1,109 $738.02
86850 404 400 $721.21
86592 360 357 $684.30
86901 399 395 $668.22
80069 237 237 $654.71
82310 1,173 1,102 $646.90
83520 341 324 $633.99
87150 40 40 $631.17
85730 553 484 $625.87
86900 368 364 $581.34
84520 1,164 1,098 $557.45
86364 33 33 $523.47
80048 Basic metabolic panel (calcium, ionized) 503 480 $521.30
84295 1,141 1,075 $521.08
84132 1,153 1,088 $508.64
83721 106 105 $482.78
82435 1,163 1,097 $481.80
86060 270 270 $467.40
82378 396 380 $456.60
82652 943 899 $442.95
80055 40 40 $420.28
85610 583 507 $350.87
86787 59 58 $288.99
84446 27 26 $280.75
86141 1,791 1,689 $275.82
85007 212 212 $269.78
81005 304 301 $256.62
86765 55 55 $256.54
86708 51 51 $243.46
82947 984 918 $240.20
81003 2,300 2,117 $228.37
86664 16 15 $216.52
84134 959 887 $214.85
82374 1,161 1,097 $204.01
86665 16 15 $202.40
82272 153 153 $199.51
82270 98 98 $193.67
86735 41 41 $192.71
86800 14 13 $168.34
87147 92 91 $162.94
82977 51 51 $162.42
36415 Collection of venous blood by venipuncture 2,197 2,132 $129.24
87205 54 54 $123.82
83718 2,781 2,617 $109.44
81002 832 814 $107.93
84681 31 30 $107.62
86663 16 15 $92.80
81000 35 34 $58.88
86431 1,278 1,212 $57.43
86310 16 15 $52.05
82465 2,820 2,654 $45.51
80051 38 38 $39.34
85045 508 495 $16.20
84156 17 16 $9.75
86677 178 169 $7.78
84155 13 12 $5.89
82247 14 12 $5.83
86039 179 172 $0.00
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 44 30 $0.00
99001 12 12 $0.00
86301 12 12 $0.00